Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. (2000). Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med343 (21), 1520-8. PMID 11087881
Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. (2005). Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med352 (11), 1092-102. PMID 15713943
Grassley CE (15 Oct 2004). Grassley questions Merck about communication with the FDA on Vioxx. 2004-10-29 ที่ เวย์แบ็กแมชชีน Press Release.
Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M (2004). Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. The Lancet (published online)
Merck & Co., (5 Nov 2004). Response to Article by Juni et al. Published in The Lancet on Nov. 5. Press Release.
Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, et al. (2005). Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med352 (11), 1081-91. PMID 15713945
Reddy, L.R.; Corey, E.J. "Facile air oxidation of the conjugate base of rofecoxib (Vioxx™), a possible contributor to chronic human toxicity" Tet. Let., 2005, 46, 927. [1]
Rouhi, A.M. "Investigating Vioxx Toxicity: Air oxidation of arthritis drug's anion forms a potentially toxic product" CN&E News, 2005, 83, 15. [2]
Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. (2005). Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med352 (11), 1071-80. PMID 15713944
Swan L, Merck Sharp & Dohme (Australia) Pty Ltd. (1 October 2004). Urgent Medicine Recall VIOXX® (rofecoxib) - Merck Announces Voluntary Worldwide Withdrawal of VIOXX.
แหล่งข้อมูลอื่น
Merck's press release announcing the withdrawal - September 30, 2004
FDA Public Health Advisory on Vioxx
David Michaels. Doubt is Their Product Scientific American, June 2004, p.96-101
โรฟ, คอกซ, rofecoxib, เป, นยาในกล, เอ, นเซด, nsaid, ใช, ในการร, กษา, โรคข, อต, ออ, กเสบอาการปวด, นแรง, และ, อาการปวดระด, นำออกวางตลาดโดย, merck, ในช, อการค, vioxx, ceoxx, และ, ceeoxx, และบร, สม, ครใจท, เอาออกจากตลาดเองใน, 2004, เพราะว, าม, นม, ความเส, ยงท, จะเ. orfikhxksib Rofecoxib epnyainklum exnesd NSAID ichinkarrksa orkhkhxtxxkesbxakarpwd runaerng aela xakarpwdradu naxxkwangtladody Merck amp Co inchuxkarkha Vioxx Ceoxx aela Ceeoxx aelabristh smkhricthiexaxxkcaktladexngin kh s 2004 ephraawamnmikhwamesiyngthicaekid klamenuxhwickhadeluxd Myocardial infarction orfikhxksibkhxmulthangkhlinikrhs ATCM01AH02 WHO twbngchiPubChem CID5090DrugBankAPRD00151ECHA InfoCard100 230 077saranukrmephschkrrmxangxing aekikhBombardier C Laine L Reicin A Shapiro D Burgos Vargas R Davis B et al 2000 Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis N Engl J Med 343 21 1520 8 PMID 11087881 Bresalier RS Sandler RS Quan H Bolognese JA Oxenius B Horgan K et al 2005 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 11 1092 102 PMID 15713943 Grassley CE 15 Oct 2004 Grassley questions Merck about communication with the FDA on Vioxx Archived 2004 10 29 thi ewyaebkaemchchin Press Release Juni P Nartey L Reichenbach S Sterchi R Dieppe PA Egger M 2004 Risk of cardiovascular events and rofecoxib cumulative meta analysis The Lancet published online Merck amp Co 5 Nov 2004 Response to Article by Juni et al Published in The Lancet on Nov 5 Press Release Nussmeier NA Whelton AA Brown MT Langford RM Hoeft A Parlow JL et al 2005 Complications of the COX 2 inhibitors parecoxib and valdecoxib after cardiac surgery N Engl J Med 352 11 1081 91 PMID 15713945 Reddy L R Corey E J Facile air oxidation of the conjugate base of rofecoxib Vioxx a possible contributor to chronic human toxicity Tet Let 2005 46 927 1 Rouhi A M Investigating Vioxx Toxicity Air oxidation of arthritis drug s anion forms a potentially toxic product CN amp E News 2005 83 15 2 Solomon SD McMurray JJ Pfeffer MA Wittes J Fowler R Finn P et al 2005 Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N Engl J Med 352 11 1071 80 PMID 15713944 Swan L Merck Sharp amp Dohme Australia Pty Ltd 1 October 2004 Urgent Medicine Recall VIOXX rofecoxib Merck Announces Voluntary Worldwide Withdrawal of VIOXX aehlngkhxmulxun aekikhMerck s press release announcing the withdrawal September 30 2004 FDA Public Health Advisory on Vioxx David Michaels Doubt is Their Product Scientific American June 2004 p 96 101 Vioxx Toxicity January 17 2005 bthkhwamekiywkbephschkrrmaelayaniyngepnokhrng khunsamarthchwywikiphiediyidodyephimkhxmul duephimthi sthaniyxy ephschkrrmekhathungcak https th wikipedia org w index php title orfikhxksib amp oldid 9555486, wikipedia, วิกิ หนังสือ, หนังสือ, ห้องสมุด,
